debrisoquin has been researched along with Diabetic Angiopathies in 1 studies
Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.
Diabetic Angiopathies: VASCULAR DISEASES that are associated with DIABETES MELLITUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gawrońska-Szklarz, B | 1 |
| Górnik, W | 1 |
| Pawlik, A | 1 |
| Kunicki, P | 1 |
| Wójcicki, J | 1 |
| Sitkiewicz, D | 1 |
| Sych, Z | 1 |
1 other study available for debrisoquin and Diabetic Angiopathies
| Article | Year |
|---|---|
N-acetylation and hydroxylation polymorphisms in type II diabetics with microvascular disturbances.
Topics: Acetylation; Adult; Aged; Debrisoquin; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Gen | 1997 |